PR Newswire Clinical TrialsOriginal article
HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027
Data ReadoutNUZ-001Positive
AI Analysis
Summary
NUZ-001 completed enrollment of 250 participants in the HEALEY ALS Platform Trial Regimen I in less than five months, setting a record for site activation and enrollment speed. Topline efficacy and safety results are now expected in late Q2 2027.
Clinical Trial Data
Patients
250
Outcome Details
Topline efficacy and safety results anticipated
Importance:6/10
Sentiment:
0.60
ALSHEALEY Platform Trialenrollmentclinical trialtopline results
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on July 17, 2026 3:48 AM